Emergence and Spread of <i>Clostridioides difficile</i> Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital
Our findings highlight the potential for the emergence on therapy of clinically relevant reduced fidaxomicin susceptibility in C. difficile and its spread via transmission to other patients.
Authors
- Piyali Chatterjee (ORCID: https://orcid.org/0000-0002-7655-0485)
- Sarah N. Redmond (ORCID: https://orcid.org/0000-0001-8412-3523)
- Munok Hwang
- Amy S. Gargis (ORCID: https://orcid.org/0000-0001-5854-2636)
- Jennifer L. Cadnum (ORCID: https://orcid.org/0000-0002-7956-9587)
- Andrew M Skinner (ORCID: https://orcid.org/0000-0001-9452-9316)
- Curtis J. Donskey (ORCID: https://orcid.org/0000-0003-0990-4498)
- Annette Jencson
- Brigid Wilson (ORCID: https://orcid.org/0000-0003-2966-2940)
- Chetan Jinadatha (ORCID: https://orcid.org/0000-0002-3916-952X)
- Ho-Soon H. Choi (ORCID: https://orcid.org/0000-0002-8272-9828)
- Claire E. Kaple (ORCID: https://orcid.org/0009-0004-5468-1910)
Institutions
- Centers for Disease Control and Prevention (US)
- VA Salt Lake City Healthcare System (US)
- Geriatric Research Education and Clinical Center (US)
- Louis Stokes Cleveland VA Medical Center (US)
- Central Texas Veterans Health Care System (US)
- University School (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1093/cid/ciaf028
- Citations
- 10
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 13.96
Funders
- U.S. Department of Veterans Affairs